Virulence factors in biofilm formation and therapeutic strategies for Staphylococcus aureus: A review
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Staphylococcus aureus ( S. aureus ) is a significant human pathogen known for its ability to form biofilms, which increase its resistance to antibiotics and immune defenses. This review delves into the mechanisms of biofilm formation in S. aureus , emphasizing the critical roles of various virulence factors. During the initial attachment phase, surface proteins such as protein A, fibronectin-binding proteins (FnBPs), and clumping factors (ClfA and ClfB) are anchored by sortase A (SrtA), facilitating adherence to host tissues and surfaces. Biofilm maturation is driven by polysaccharide intercellular adhesin (PIA), while the extracellular polymeric substance (EPS) matrix—comprising polysaccharides, extracellular DNA, proteins, and lipids—reinforces biofilm stability and defense mechanisms. Regulatory systems such as MgrA, ClpP, and the SaeR/SaeS two-component system dynamically modulate the expression of virulence and biofilm-associated genes, enabling bacterial adaptation to environmental stressors. Additionally, toxins such as alpha-hemolysin (Hla) and enzymes such as coagulase (Coa) and von Willebrand factor-binding protein (vWbp) play pivotal roles in immune evasion and biofilm protection. This review also explores emerging therapeutic strategies that target these virulence factors, highlighting their potential in treating persistent S. aureus infections. Understanding the intricate interplay between virulence factors and biofilm formation provides valuable insights for developing of more effective therapeutic interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The incorporation of MSCRAMMs into the biofilm structure not only enhances bacterial persistence but also increases the pathogenicity of S. aureus strains, particularly in infections related to implants and bloodstream infections associated with catheters [78,87].”
From Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms (2025) · cites this paper as [78]
In the citing paper
“Moreover, recent findings have underscored the role of SarA in modulating toxin production during osteomyelitis, highlighting its contribution to bone infections through regulating extracellular proteases and virulence factors [78,171].”
From Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms (2025) · cites this paper as [78]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biomedical applications of nisin
Shin, J. M., Gwak, J. W., Kamarajan, P., Fenno, J. C., Rickard, A. H., & Kapila, Y. L. (2016) · Journal of Applied Microbiology · doi:10.1111/jam.13033 · Cited by 607
A Review of Biofilm Formation of Staphylococcus aureus and Its Regulation Mechanism
Peng, Q., Tang, X., Dong, W., Sun, N., & Yuan, W. (2022) · Antibiotics · doi:10.3390/antibiotics12010012 · Cited by 440
Saidi, N., Saderi, H., Owlia, P., & Soleimani, M. (2023) · Advanced Biomedical Research · doi:10.4103/abr.abr_156_21 · Cited by 34
Research works printed but not linked: 253
- Gherardi, 2023, Staphylococcus aureus infection: pathogenesis and antimicrobial resistance, MDPI, 8182
- T.L.Holland, Ceftobiprole for treatment of complicated Staphylococcus aureus bacteremia. 2023. 389(15): p. 1390–1401. https://doi.org/10.1056/NEJMoa2300220 · DOI · Paper page
- B.P.Howden, Staphylococcus aureus host interactions and adaptation. 2023. 21(6): p. 380–95. https://doi.org/10.1038/s41579-023-00852-y · DOI · Paper page
- M.S.Linz, Clinical impact of Staphylococcus aureus skin and soft tissue infections. 2023. 12(3): p. 557. https://doi.org/10.3390/antibiotics12030557 · DOI · Paper page
- Kebriaei, R., et al., Optimization of phage-antibiotic combinations against Staphylococcus aureus biofilms. 2023. 11(3): p. e04918–22. https://doi.org/10.1128/spectrum.04918-22 · DOI · Paper page
- M.Khaleghian, In silico design and mechanistic study of niosome-encapsulated curcumin against multidrug-resistant Staphylococcus aureus biofilms. 2023. 14: p. 1277533. https://doi.org/10.3389/fmicb.2023.1277533 · doi:10.3389/fmicb.2023.1277533
- M.Malani, Carboxylated nanofibrillated cellulose empowers moxifloxacin to overcome Staphylococcus aureus biofilm in bacterial keratitis. 2024. 324: p. 121558. https://doi.org/10.1016/j.carbpol.2023.121558 · DOI
- Mao, Y., et al., Baicalein inhibits the Staphylococcus aureus biofilm and the LuxS/AI-2 system in vitro. 2023: p. 2861–82. https://doi.org/10.2147/IDR.S406243 · DOI
- N.N.Tran, Current therapies and challenges for the treatment of Staphylococcus aureus biofilm-related infections. 2023. 43(8): p. 816–32. https://doi.org/10.1002/phar.2806 · DOI
- Wu, X., et al., Staphylococcus aureus biofilm: formulation, regulatory, and emerging natural products-derived therapeutics. 2024: p. 100175. https://doi.org/10.1016/j.bioflm.2023.100175 · DOI
- Yap, C.H., et al., Synthesis and Staphylococcus aureus biofilm inhibitory activity of indolenine-substituted pyrazole and pyrimido [1, 2-b] indazole derivatives. 2023. 95: p. 117485. https://doi.org/10.1016/j.bmc.2023.117485 · DOI
- Yu, Y.-L., et al., Elimination of methicillin-resistant Staphylococcus aureus biofilms on titanium implants via photothermally-triggered nitric oxide and immunotherapy for enhanced osseointegration. 2023. 10(1): p. 21. https://doi.org/10.1186/s40779-023-00454-y · DOI
- Tabassum, N., et al., Treatment of Staphylococcus aureus and Candida albicans polymicrobial biofilms by phloroglucinol-gold nanoparticles. 2023. 185: p. 106416. https://doi.org/10.1016/j.micpath.2023.106416 · DOI
- Fernández-Grajera, M., et al., Dynamic adhesive behavior and biofilm formation of staphylococcus aureus on polylactic acid surfaces in diabetic environments. 2024. 17(13): p. 3349. https://doi.org/10.3390/ma17133349 · DOI
- Hernández-Cuellar, E., et al., Differences in biofilm formation by methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains. 2023. 11(4): p. 160. https://doi.org/10.3390/diseases11040160 · DOI
- Martínez, A., et al., Effect of essential oil from Lippia origanoides on the transcriptional expression of genes related to quorum sensing, biofilm formation, and virulence of Escherichia coli and Staphylococcus aureus. 2023. 12(5): p. 845. https://doi.org/10.3390/antibiotics12050845 · DOI
- Long, D.R., et al., In vitro selection identifies Staphylococcus aureus genes influencing biofilm formation. 2023. 91(3): p. e00538–22. https://doi.org/10.1128/iai.00538-22 · doi:10.1128/iai.00538-22
- Vargová, M., et al., Biofilm-producing ability of Staphylococcus aureus obtained from surfaces and milk of mastitic cows. 2023. 10(6): p. 386. https://doi.org/10.3390/vetsci10060386 · DOI
- Ciszek-Lenda, M., et al., Biofilm-forming strains of P. aeruginosa and S. aureus isolated from cystic fibrosis patients differently affect inflammatory phenotype of macrophages. 2023. 72(6): p. 1275–89. https://doi.org/10.1007/s00011-023-01743-x · DOI
- Xiao, Y., et al., Novel small-molecule compound YH7 inhibits the biofilm formation of Staphylococcus aureus in a sarX-dependent manner. 2024. 9(1): p. e00564–23. https://doi.org/10.1128/msphere.00564-23 · DOI
- Ramachandran, G., et al., Chitosan/silver nanocomposites enhanced the biofilm eradication in biofilm forming Gram positive S. aureus. 2023. 35(4): p. 102597. https://doi.org/10.1016/j.jksus.2023.102597 · doi:10.1016/j.jksus.2023.102597
- Bai, X., et al., Anti-biofilm activity of biochanin A against Staphylococcus aureus. 2023. 107(2): p. 867–79. https://doi.org/10.1007/s00253-022-12350-x · doi:10.1007/s00253-022-12350-x
- Luo, Z.-x., et al., Ciprofloxacin enhances the biofilm formation of Staphylococcus aureus via an agrC-dependent mechanism. 2023. 14: p. 1328947. https://doi.org/10.3389/fmicb.2023.1328947 · DOI
- Li, M., et al., Interactions between macrophages and biofilm during Staphylococcus aureus-associated implant infection: difficulties and solutions. 2023. 15(1): p. 499–515. https://doi.org/10.1159/000530385 · DOI
- Omar, W.H.W., et al., Effect of natural antibacterial clays against single biofilm formation by Staphylococcus aureus and Salmonella Typhimurium bacteria on a stainless-steel surface. 2023. 394: p. 110184. https://doi.org/10.1016/j.ijfoodmicro.2023.110184 · doi:10.1016/j.ijfoodmicro.2023.110184
- Dai, J., et al., Occurrence, antibiotic susceptibility, biofilm formation and molecular characterization of Staphylococcus aureus isolated from raw shrimp in China. 2023. 12(14): p. 2651. https://doi.org/10.3390/foods12142651 · DOI
- François, P., J. Schrenzel, F. Götz, Biology and regulation of staphylococcal biofilm. 2023. 24(6): p. 5218. https://doi.org/10.3390/ijms24065218 · DOI
- Shaghayegh, G., et al., Staphylococcus aureus biofilm properties and chronic rhinosinusitis severity scores correlate positively with total CD4+ T-cell frequencies and inversely with its Th1, Th17 and regulatory cell frequencies. 2023. 170(1): p. 120–33. https://doi.org/10.1111/imm.13655 · DOI
- Yadav, M.K., A. Baldia, S.K. Tiwari, Plantaricin LD1 inhibits the growth and biofilm formation of Staphylococcus aureus in milk. 2024. 9(1): p. 1–7. https://doi.org/10.14218/jerp.2023.00011 · DOI
- Tuon, F.F., et al., Antimicrobial treatment of Staphylococcus aureus biofilms. 2023. 12(1): p. 87. https://doi.org/10.3390/antibiotics12010087 · DOI · Paper page
- Liang, J., et al., Biofilm formation of two genetically diverse Staphylococcus aureus isolates under beta-lactam antibiotics. 2023. 14: p. 1139753. https://doi.org/10.3389/fmicb.2023.1139753 · DOI
- Shaghayegh, G., et al., Chronic rhinosinusitis patients display an aberrant immune cell localization with enhanced S aureus biofilm metabolic activity and biomass. 2023. 151(3): p. 723–36. e16. https://doi.org/10.1016/j.jaci.2022.08.031 · DOI
- Sharan, M., et al., Characterization of chicken eggs associated Escherichia coli and Staphylococcus aureus for biofilm production and antimicrobial resistance traits. 2023. 34(8): p. 3533–44. https://doi.org/10.1080/10495398.2023.2171423 · DOI
- Jeong, G.-J., et al., Controlling biofilm and virulence properties of Gram-positive bacteria by targeting wall teichoic acid and lipoteichoic acid. 2023: p. 106941. https://doi.org/10.1016/j.ijantimicag.2023.106941 · DOI
- Mamdoh, H., et al., Clinical and bacteriological analyses of biofilm-forming Staphylococci isolated from diabetic foot ulcers. 2023: p. 1737–50. https://doi.org/10.2147/IDR.S393724 · DOI
- Hamad PA. Phenotypic and molecular detection of biofilm formation in methicillin-resistant Staphylococcus aureus isolated from different clinical sources in Erbil city. 2023. 1: p. 15. https://doi.org/10.4084/MJHID.2023.016 · doi:10.4084/mjhid.2023.016
- Katsipis, G., A.A. Pantazaki, Serrapeptase impairs biofilm, wall, and phospho-homeostasis of resistant and susceptible Staphylococcus aureus. 2023. 107(4): p. 1373–89. https://doi.org/10.1007/s00253-022-12356-5 · DOI
- Li, H., et al., Cuminaldehyde inhibits biofilm formation by affecting the primary adhesion of Staphylococcus aureus. 2023. 156: p. 13–20. https://doi.org/10.1016/j.sajb.2023.02.031 · doi:10.1016/j.sajb.2023.02.031
- Zhu, Z., et al., Molecular characteristics and pathogenicity of staphylococcus aureus exotoxins. 2023. 25(1): p. 395. https://doi.org/10.3390/ijms25010395 · DOI
- Sun, J., et al., Antimicrobial nanostructured assemblies with extremely low toxicity and potent activity to eradicate Staphylococcus aureus biofilms. 2023. 19(3): p. 2204039. https://doi.org/10.1002/smll.202204039 · DOI
- Parvin, F., et al., Staphylococcus aureus cell wall phenotypic changes associated with biofilm maturation and water availability: a key contributing factor for chlorine resistance. 2023. 24(5): p. 4983. https://doi.org/10.3390/ijms24054983 · DOI
- Peng, Q., et al., Carvacrol inhibits bacterial polysaccharide intracellular adhesin synthesis and biofilm formation of mucoid Staphylococcus aureus: an in vitro and in vivo study. 2023. 13(41): p. 28743–52. https://doi.org/10.1039/d3ra02711b · DOI
- Tello-Díaz, C., et al., Methicillin-susceptible Staphylococcus aureus biofilm formation on vascular grafts: an in vitro study. 2023. 11(2): p. e03931–22. https://doi.org/10.1128/spectrum.03931-22 · doi:10.1128/spectrum.03931-22
- Ersanli, C., et al., The assessment of antimicrobial and anti-biofilm activity of essential oils against Staphylococcus aureus strains. 2023. 12(2): p. 384. https://doi.org/10.3390/antibiotics12020384 · DOI
- Shen, L., et al., Small-molecule compound CY-158-11 inhibits Staphylococcus aureus biofilm formation. 2023. 11(3): p. e00045–23. https://doi.org/10.1128/spectrum.00045-23 · DOI
- Rather, I.A., et al., Limosilactobacillus fermentum KAU0021 abrogates mono-and polymicrobial biofilms formed by Candida albicans and Staphylococcus aureus. 2023. 15(4): p. 1079. https://doi.org/10.3390/pharmaceutics15041079 · DOI
- Xu, Z., et al., Cell-wall-anchored proteins affect invasive host colonization and biofilm formation in Staphylococcus aureus. 2024: p. 127782. https://doi.org/10.1016/j.micres.2024.127782 · DOI
- Bhattacharya M, Horswill AR. The role of human extracellular matrix proteins in defining Staphylococcus aureus biofilm infections. 2024. 48(1): pfuae002. https://doi.org/10.1093/femsre/fuae002 · DOI · Paper page
- Motta, C., et al., von Willebrand factor-binding protein (vWbp)-activated factor XIII and transglutaminase 2 (TG2) promote cross-linking between FnBPA from Staphylococcus aureus and fibrinogen. 2023. 13(1): p. 11683. https://doi.org/10.1038/s41598-023-38972-3 · doi:10.1038/s41598-023-38972-3
- Risser, F., et al., Adhesive virulence factors of Staphylococcus aureus resist digestion by coagulation proteases thrombin and plasmin. 2022. 2(6): p. 586–99. https://doi.org/10.1021/acsbiomedchemau.2c00042 · DOI
- Torres, G., et al., Evaluation of three Staphylococcus aureus proteins involved in the adhesion process as antigens for the detection of bovine intramammary infections. 2022. 71(12): p. 001613. https://doi.org/10.1099/jmm.0.001613 · DOI
- Speziale P, Pietrocola G. Monoclonal antibodies targeting surface-exposed and secreted proteins from staphylococci. 2021. 9(5): p459. https://doi.org/10.3390/vaccines9050459 · DOI · Paper page
- Berry, K.A., et al., Staphylococcus aureus adhesion to the host. 2022. 1515(1): p. 75–96. https://doi.org/10.1111/nyas.14807 · DOI
- Schnurr, E., et al., Staphylococcus aureus interferes with streptococci spatial distribution and with protein expression of species within a polymicrobial oral biofilm. 2021. 10(2): p. 116. https://doi.org/10.3390/antibiotics10020116 · DOI
- Mirzaei, B., et al., Staphylococcal vaccine antigens related to biofilm formation. 2021. 17(1): p. 293–303. https://doi.org/10.1080/21645515.2020.1767449 · DOI
- Wu, S., et al., The role of Staphylococcus aureus YycFG in gene regulation, biofilm organization and drug resistance. 2021. 10(12): p. 1555. https://doi.org/10.3390/antibiotics10121555 · DOI
- Ortega-Peña, S., et al., Overview of Staphylococcus epidermidis cell wall-anchored proteins: potential targets to inhibit biofilm formation. 2020. 47: p. 771–84. https://doi.org/10.1007/s11033-019-05139-1 · DOI
- Chan, Y.L., et al., Unveilling genetic profiles and correlations of biofilm-associated genes, quorum sensing, and antibiotic resistance in Staphylococcus aureus isolated from a Malaysian Teaching Hospital. 2024. 29(1): p. 246. https://doi.org/10.1186/s40001-024-01831-6 · doi:10.1186/s40001-024-01831-6
- Király, J., et al., Resistant S. aureus Isolates capable of producing biofilm from the milk of dairy cows with subclinical mastitis in Slovakia. 2024. 14(4): p. 571. https://doi.org/10.3390/agriculture14040571 · DOI
- Kaźmierczak, N., B. Grygorcewicz, L. Piechowicz, Biofilm formation and prevalence of biofilm-related genes among clinical strains of multidrug-resistant Staphylococcus aureus. 2021. 27(7): p. 956–64. https://doi.org/10.1089/mdr.2020.0399 · doi:10.1089/mdr.2020.0399
- Parastan, R., et al., Staphylococcus aureus biofilms: structures, antibiotic resistance, inhibition, and vaccines. 2020. 20: p. 100739. https://doi.org/10.1016/j.genrep.2020.100739 · DOI · Paper page
- Hait, J.M., et al., Evaluation of virulence determinants using whole-genome sequencing and phenotypic biofilm analysis of outbreak-linked Staphylococcus aureus isolates. 2021. 12: p. 687625. https://doi.org/10.3389/fmicb.2021.687625 · doi:10.3389/fmicb.2021.687625
- Tomlinson, B.R., M.E. Malof, L.N. Shaw, A global transcriptomic analysis of Staphylococcus aureus biofilm formation across diverse clonal lineages. 2021. 7(7): p. 000598. https://doi.org/10.1099/mgen.0.000598 · DOI
- Nguyen, H.T., et al., The staphylococcal exopolysaccharide PIA–biosynthesis and role in biofilm formation, colonization, and infection. 2020. 18: p. 3324–34. https://doi.org/10.1016/j.csbj.2020.10.027 · DOI · Paper page
- Hao, Z., et al., Deletion of SarX decreases biofilm formation of Staphylococcus aureus in a polysaccharide intercellular adhesin (PIA)-dependent manner by downregulating spa. 2021: p. 2241–50. https://doi.org/10.2147/IDR.S305650 · DOI
- e Silva, A.Ad.L., et al., Diclofenac may induce PIA-independent biofilm formation in Staphylococcus aureus strains. 2021. 2021. https://doi.org/10.1155/2021/8823775 · DOI
- Azzam, A., R.M. Shawky, T.S. El-Mahdy, Sub-inhibitory concentrations of ceftriaxone induce morphological alterations and PIA-independent biofilm formation in Staphylococcus aureus. 2024. 55(1): p. 297–308. https://doi.org/10.1007/s42770-023-01177-x · DOI
- Mirzaei, B., et al., PIA and rSesC mixture arisen antibodies could inhibit the biofilm-formation in Staphylococcus aureus. 2021. 10(1): p. 1. https://doi.org/10.52547/rbmb.10.1.1 · DOI
- Idrees, M., et al., Staphylococcus aureus biofilm: morphology, genetics, pathogenesis and treatment strategies. 2021. 18(14): p. 7602. https://doi.org/10.3390/ijerph18147602 · DOI · Paper page
- Nasser, A., et al., Staphylococcus aureus: biofilm formation and strategies against it. 2022. 23(5): p. 664–78. https://doi.org/10.2174/1389201022666210708171123 · DOI
- Zhang, C., et al., Berberine at sub-inhibitory concentration inhibits biofilm dispersal in Staphylococcus aureus. 2022. 168(9): p. 001243. https://doi.org/10.1099/mic.0.001243 · DOI
- Silva-Santana, G., et al., Staphylococcus aureus biofilms: an opportunistic pathogen with multidrug resistance. 2021. 32(1): p. 12–21. https://doi.org/10.1097/MRM.0000000000000223 · DOI
- Piras, C., et al., S. aureus biofilm protein expression linked to antimicrobial resistance: a proteomic study. 2021. 11(4): p. 966. https://doi.org/10.3390/ani11040966 · DOI
- Qi, M., et al., Staphylococcus aureus biofilm inhibition by high voltage prick electrostatic field (HVPEF) and the mechanism investigation. 2022. 362: p. 109499. https://doi.org/10.1016/j.ijfoodmicro.2021.109499 · DOI
- e Silva, A.Ad.L., et al., Research article diclofenac may induce PIA-independent biofilm formation in Staphylococcus aureus Strains. 2021. https://doi.org/10.1155/2021/8823775 · DOI
- Lamret, F., et al., Staphylococcus aureus strain-dependent biofilm formation in bone-like environment. 2021. 12: p. 714994. https://doi.org/10.3389/fmicb.2021.714994 · DOI
- Cáceres, M.E., et al., Growth conditions affect biofilms of Staphylococcus aureus producing mastitis: contribution of MALDI-TOF-MS to strain characterization. 2021. 2: p. 100073. https://doi.org/10.1016/j.crmicr.2021.100073 · doi:10.1016/j.crmicr.2021.100073
- Qiao, J., et al., Research on the biofilm formation of Staphylococcus aureus after cold stress. 2021. 9(7): p. 1534.https://doi.org/10.3390/microorganisms9071534 · doi:10.3390/microorganisms9071534
- Rahman, M.A., et al., Proteome of Staphylococcus aureus biofilm changes significantly with aging. 2022. 23(12): p. 6415. https://doi.org/10.3390/ijms23126415 · DOI
- Schwartbeck, B., et al., Various mutations in icaR, the repressor of the icaADBC locus, occur in mucoid Staphylococcus aureus isolates recovered from the airways of people with cystic fibrosis. 2024. 26(4): p. 105306. https://doi.org/10.1016/j.micinf.2024.105306 · DOI
- Mu, Y., et al., Streptomyces-derived actinomycin D inhibits biofilm formation via downregulating ica locus and decreasing production of PIA in Staphylococcus epidermidis. 2020. 128(4): p. 1201–7. https://doi.org/10.1111/jam.14543 · DOI
- Spiegel, C., S.J.M. Steixner, D.C. Coraça-Huber, Antibiofilm activity of omega-3 fatty acids and its influence on the expression of biofilm formation genes on Staphylococcus aureus. 2022. 11(7): p. 932. https://doi.org/10.3390/antibiotics11070932 · DOI
- Li, H., et al., Inhibition mechanism of cyclo (L-Phe-L-Pro) on early stage Staphylococcus aureus biofilm and its application on food contact surface. 2022. 49: p. 101968. https://doi.org/10.1016/j.fbio.2022.101968 · DOI
- Sang, H., et al., Gallic acid exerts antibiofilm activity by inhibiting methicillin-resistant Staphylococcus aureus adhesion. 2024. 14(1): p. 17220. https://doi.org/10.1038/s41598-024-68279-w · DOI
- Vila, T., et al., Therapeutic implications of C. albicans-S. aureus mixed biofilm in a murine subcutaneous catheter model of polymicrobial infection. 2021. 12(1): p. 835–51. https://doi.org/10.1080/21505594.2021.1894834 · DOI
- Bulock, L.L., et al., Interplay of CodY and CcpA in regulating central metabolism and biofilm formation in Staphylococcus aureus. 2022. 204(7): p. e00617–21. https://doi.org/10.1128/jb.00617-21 · DOI
- Avila-Novoa, M.G., et al., Staphylococcus aureus and methicillin-resistant S. aureus (MRSA) strains isolated from dairy products: relationship of ica-dependent/independent and components of biofilms produced in vitro. 2021. 119: p. 105066. https://doi.org/10.1016/j.idairyj.2021.105066 · DOI
- Guo, N., et al., Target-based screening for natural products against Staphylococcus aureus biofilms. 2023. 63(14): p. 2216–2230. https://doi.org/10.1080/10408398.2021.1972280 · doi:10.1080/10408398.2021.1972280
- Pietrocola, G., et al., Colonization and infection of indwelling medical devices by Staphylococcus aureus with an emphasis on orthopedic implants. 2022. 23(11): p. 5958. https://doi.org/10.3390/ijms23115958 · DOI
- Kot, B., et al., Effect of manuka honey on biofilm-associated genes expression during methicillin-resistant Staphylococcus aureus biofilm formation. 2020. 10(1): p. 13552. https://doi.org/10.1038/s41598-020-70666-y · DOI · Paper page
- Marincola, G., et al., Plasmid-chromosome crosstalk in Staphylococcus aureus: a horizontally acquired transcription regulator controls polysaccharide intercellular adhesin-mediated biofilm formation. 2021. 11: p. 660702. https://doi.org/10.3389/fcimb.2021.660702 · DOI
- Ball, A.L., et al., Characterization of Staphylococcus aureus biofilms via crystal violet binding and biochemical composition assays of isolates from hospitals, raw meat, and biofilm-associated gene mutants. 2022. 167: p. 105554. https://doi.org/10.1016/j.micpath.2022.105554 · DOI
- Liu, Y., J. Zhang, Y. Ji, Environmental factors modulate biofilm formation by Staphylococcus aureus. 2020. 103(1): p. 0036850419898659. https://doi.org/10.1177/0036850419898659 · DOI
- Yuan, Z., et al., Thymol inhibits biofilm formation, eliminates pre-existing biofilms, and enhances clearance of methicillin-resistant Staphylococcus aureus (MRSA) in a mouse peritoneal implant infection model. 2020. 8(1): p. 99. https://doi.org/10.3390/microorganisms8010099 · DOI · Paper page
- Bowden, L.C., et al., Beyond the double helix: the multifaceted landscape of extracellular DNA in Staphylococcus aureus biofilms. 2024. 14: p. 1400648. https://doi.org/10.3389/fcimb.2024.1400648 · DOI
- Ravaioli, S., et al., Various biofilm matrices of the emerging pathogen Staphylococcus lugdunensis: exopolysaccharides, proteins, eDNA and their correlation with biofilm mass. 2020. 36(1): p. 86–100. https://doi.org/10.1080/08927014.2020.1716217 · DOI
- Sivori, F., et al., Role of extracellular DNA in dalbavancin activity against methicillin-resistant Staphylococcus aureus (MRSA) biofilms in patients with skin and soft tissue infections. 2022. 10(2): p. e00351–22. https://doi.org/10.1128/spectrum.00351-22 · DOI
- Tian, L.-L., et al., Low concentrations of tetrabromobisphenol A promote the biofilm formation of methicillin-resistant Staphylococcus aureus. 2024. 283: p. 116853. https://doi.org/10.1016/j.ecoenv.2024.116853 · DOI
- Kaplan JB, Horswill AR. Micrococcal nuclease regulates biofilm formation and dispersal in methicillin-resistant Staphylococcus aureus USA300. 2024. 9(5): p. e00126–24. https://doi.org/10.1128/msphere.00126-24 · DOI
- Mlynek, K.D., et al., Genetic and biochemical analysis of CodY-mediated cell aggregation in Staphylococcus aureus reveals an interaction between extracellular DNA and polysaccharide in the extracellular matrix. 2020. 202(8): p. 10.1128/jb. 00593-19. https://doi.org/10.1128/JB.00593-19 · DOI · Paper page
- Panlilio, H., C.V. Rice, The role of extracellular DNA in the formation, architecture, stability, and treatment of bacterial biofilms. 2021. 118(6): p. 2129–41. https://doi.org/10.1002/bit.27760 · DOI · Paper page
- Ong, Z.X., et al., Investigation of Staphylococcus aureus biofilm-associated toxin as a potential squamous cell carcinoma therapeutic. 2024. 12(2): p. 293. https://doi.org/10.3390/microorganisms12020293 · DOI
- Fesharaki, M.J., et al., Virulence factors of Staphylococcus aureus hemolysin HLA and HLB isolated from catheters of dialysis patients referred to Nikan Hospital in Tehran during the spring and summer of 2021. 2022. 16(6): p. 348. https://doi.org/10.52547/ijkd.7146 · doi:10.52547/ijkd.7146
- Motallebi, M., et al., Molecular analysis and the toxin, MSCRAMM, and biofilm genes of methicillin-resistant Staphylococcus aureus strains isolated from pemphigus wounds: a study based on SCCmec and dru typing. 2021. 87: p. 104644. https://doi.org/10.1016/j.meegid.2020.104644 · doi:10.1016/j.meegid.2020.104644
- Wang, T., et al., A natural dietary flavone myricetin as an α-hemolysin inhibitor for controlling Staphylococcus aureus infection. 2020. 10: p. 330. https://doi.org/10.3389/fcimb.2020.00330 · DOI
- Guo, H., et al., Biofilm and small colony variants—an update on Staphylococcus aureus strategies toward drug resistance. 2022. 23(3): p. 1241. https://doi.org/10.3390/ijms23031241 · DOI · Paper page
- Heim, C.E., et al., Lactate production by Staphylococcus aureus biofilm inhibits HDAC11 to reprogramme the host immune response during persistent infection. 2020. 5(10): p. 1271–84. https://doi.org/10.1038/s41564-020-0756-3 · DOI · Paper page
- De Gregorio, E., et al., N-nonyloxypentyl-l-deoxynojirimycin inhibits growth, biofilm formation and virulence factors expression of Staphylococcus aureus. 2020. 9(6): p. 362. https://doi.org/10.3390/antibiotics9060362 · DOI
- Zheng, J., et al., Diclazuril inhibits biofilm formation and hemolysis of Staphylococcus aureus. 2021. 7(6): p. 1690–701. https://doi.org/10.1021/acsinfecdis.1c00030 · DOI
- Liu, Y., et al., Lapatinib acts against biofilm formation and the hemolytic activity of Staphylococcus aureus. 2022. 7(10): p. 9004–14. https://doi.org/10.1021/acsomega.2c00174 · DOI
- Hussain, M., C. Kohler, K. Becker, Role of SrtA in pathogenicity of Staphylococcus lugdunensis. 2020. 8(12): p. 1975. https://doi.org/10.3390/microorganisms8121975 · DOI
- Thappeta, K.R.V., et al., In-silico identified new natural sortase a inhibitors disrupt S. aureus biofilm formation. 2020. 21(22): p. 8601. https://doi.org/10.3390/ijms21228601 · DOI
- Yang, T., et al., Tideglusib and its analogues as inhibitors of Staphylococcus aureus SrtA. 2020. 63(15): p. 8442–57. https://doi.org/10.1021/acs.jmedchem.0c00803 · DOI
- Song, W., et al., Hibifolin, a natural sortase a inhibitor, attenuates the pathogenicity of Staphylococcus aureus and enhances the antibacterial activity of cefotaxime. 2022. 10(4): p. e00950–22. https://doi.org/10.1128/spectrum.00950-22 · DOI
- Yue, C., et al., Structure-guided design, synthesis, and antivirulence assessment of covalent Staphylococcus aureus sortase A inhibitors. 2024. 67(2): p. 1127–46. https://doi.org/10.1021/acs.jmedchem.3c01615 · DOI
- Wang, X., et al., The protection effect of rhodionin against methicillin-resistant Staphylococcus aureus-induced pneumonia through sortase A inhibition. 2023. 39(1): p. 18. https://doi.org/10.1007/s11274-022-03457-4 · DOI
- Wang, L., et al., Eriodictyol as a potential candidate inhibitor of sortase A protects mice from methicillin-resistant Staphylococcus aureus-induced pneumonia. 2021. 12: p. 635710. https://doi.org/10.3389/fmicb.2021.635710 · DOI
- Tian, L., et al., Exploring the modulatory impact of isosakuranetin on Staphylococcus aureus: Inhibition of sortase A activity and α-haemolysin expression. 2023. 14(1): p. 2260675. https://doi.org/10.1080/21505594.2023.2260675 · DOI
- Guan, X.-N., et al., Covalent sortase A inhibitor ML346 prevents Staphylococcus aureus infection of Galleria mellonella. 2022. 13(2): p. 138–49. https://doi.org/10.1039/d1md00316j · DOI
- Volynets, G.P., et al., Identification of novel small-molecular inhibitors of Staphylococcus aureus sortase A using hybrid virtual screening. 2022. 75(6): p. 321–32. https://doi.org/10.1038/s41429-022-00524-8 · DOI
- Nairn, B.L., et al., Uncovering roles of Streptococcus gordonii SrtA-processed proteins in the biofilm lifestyle. 2020. 203(2): p. 10.1128/jb. 00544-20. https://doi.org/10.1128/JB.00544-20 · DOI
- Kuai, 2024, Role of SarA in Staphylococcus aureus: a virulence target for therapeutic strategies, Prog Microbes Mol Biol, 7, 10.36877/pmmb.a0000444 · doi:10.36877/pmmb.a0000444
- Patel, 2023, A genetic regulatory see-saw of biofilm and virulence in MRSA pathogenesis, Front Microbiol, 14, 1204428, 10.3389/fmicb.2023.1204428 · DOI
- Zhang, 2017, Chalcone attenuates Staphylococcus aureus virulence by targeting sortase A and alpha-hemolysin, Front Microbiol, 8, 1715, 10.3389/fmicb.2017.01715 · DOI · Paper page
- Wang, 2018, Oligopeptide targeting sortase a as potential anti-infective therapy for Staphylococcus aureus, Front Microbiol, 9, 245, 10.3389/fmicb.2018.00245 · DOI
- Crosby, H.A., et al., The Staphylococcus aureus ArlRS two-component system regulates virulence factor expression through MgrA. 2020. 113(1): p. 103–22. https://doi.org/10.1111/mmi.14404 · DOI · Paper page
- Guo, X., et al., Thwarting resistance: MgrA inhibition with methylophiopogonanone a unveils a new battlefront against S. aureus. 2024. 10(1): p. 15. https://doi.org/10.1038/s41522-024-00485-w · DOI
- Lee, J., et al., Functional mgrA influences genetic changes within a Staphylococcus aureus cell population over time. 2022. 204(10): p. e00138–22. https://doi.org/10.1128/jb.00138-22 · DOI
- Zheng, J., et al., Loratadine interacts with MgrA and inhibits Staphylococcus aureus virulence and biofilm formation. https://doi.org/10.1128/jb.00138-22 · DOI
- Chen, L., et al., The role of graRS in regulating virulence and antimicrobial resistance in methicillin-resistant Staphylococcus aureus. 2021. 12: p. 727104. https://doi.org/10.3389/fmicb.2021.727104 · DOI
- Kwiecinski, J.M., et al., Therapeutic inhibition of Staphylococcus aureus ArlRS two-component regulatory system blocks virulence. 2022. 66(7): p. e00187–22. https://doi.org/10.1128/aac.00187-22 · DOI
- Patel H, Rawat S. A genetic regulatory see-saw of biofilm and virulence in MRSA pathogenesis. 2023: p. 1204428. https://doi.org/10.3389/fmicb.2023.1204428 · DOI
- Crosby, H.A., et al., Host-derived protease promotes aggregation of Staphylococcus aureus by cleaving the surface protein SasG. 2024. 15(4): p. e03483–23. https://doi.org/10.1128/mbio.03483-23 · DOI
- Aggarwal S, Singh DV. Efflux pumps and biofilm formation by both methicillin-resistant and methicillin-sensitive Staphylococcus aureus strains. 2020. 58(08): p527–38. https://doi.org/10.56042/ijeb.v58i08.39406 · doi:10.56042/ijeb.v58i08.39406
- Lei, M.G., et al., Characterization of Ssc, an N-acetylgalactosamine-containing Staphylococcus aureus surface polysaccharide. 2024. 206(5): p. e00048–24. https://doi.org/10.1128/jb.00048-24 · doi:10.1128/jb.00048-24
- Costa, Md.O.Ce, et al., The gene regulatory network of Staphylococcus aureus ST239-SCC mec III strain Bmb9393 and assessment of genes associated with the biofilm in diverse backgrounds. 2023. 13: p. 1049819. https://doi.org/10.3389/fmicb.2022.1049819 · DOI
- Kim, S.-Y., M. Kim, T.-J.. Kim, Regulation of σB-dependent biofilm formation in Staphylococcus aureus through strain-specific signaling induced by diosgenin. 2023. 11(10): p. 2376. https://doi.org/10.3390/microorganisms11102376 · DOI
- Yu, Y., et al., Inhibition of efflux pump encoding genes and biofilm formation by sub-lethal photodynamic therapy in methicillin susceptible and resistant Staphylococcus aureus. 2022. 39: p. 102900. https://doi.org/10.1016/j.pdpdt.2022.102900 · doi:10.1016/j.pdpdt.2022.102900
- Elgrail, M.M., et al., Convergent evolution of antibiotic tolerance in patients with persistent methicillin-resistant Staphylococcus aureus bacteremia. 2022. 90(4): p. e00001–22. https://doi.org/10.1128/iai.00001-22 · DOI
- Yu, X., et al., Increased expression of efflux pump NorA drives the rapid evolutionary trajectory from tolerance to resistance against ciprofloxacin in Staphylococcus aureus. 2022. 66(12): p. e00594–22. https://doi.org/10.1128/aac.00594-22 · DOI
- Queraltó, 2023, Role and regulation of Clp proteases: a target against gram-positive bacteria, Bacteria, 2, 21, 10.3390/bacteria2010002 · DOI
- Ju, Y., et al., Recent advances in Clp protease modulation to address virulence, resistance and persistence of MRSA infection. 2021. 26(9): p. 2190–7. https://doi.org/10.1016/j.drudis.2021.05.014 · DOI
- Zheng, J., et al., ClpP participates in stress tolerance, biofilm formation, antimicrobial tolerance, and virulence of Enterococcus faecalis. 2020. 20: p. 1–18. https://doi.org/10.1186/s12866-020-1719-9 · DOI
- Wei, B., et al., Anti-infective therapy using species-specific activators of Staphylococcus aureus ClpP. 2022. 13(1): p. 6909. https://doi.org/10.1038/s41467-022-34753-0 · DOI
- Xu, L., et al., A clinically selected Staphylococcus aureus clpP mutant survives daptomycin treatment by reducing binding of the antibiotic and adapting a rod-shaped morphology. 2023. 67(6): p. e00328–23. https://doi.org/10.1128/aac.00328-23 · DOI
- R.Nassar, Microbial metabolic genes crucial for S. aureus biofilms: an insight from re-analysis of publicly available microarray datasets. 2021. 11: p. 607002. https://doi.org/10.3389/fmicb.2020.607002 · DOI · Paper page
- Feng, Y., et al., Effects of ClpP protease on biofilm formation of Enterococcus faecalis. 2021. 29: p. e20200733. https://doi.org/10.1590/1678-7757-2020-0733 · DOI
- Liu, 2017, The ATP-dependent protease ClpP inhibits biofilm formation by regulating Agr and cell wall hydrolase Sle1 in Staphylococcus aureus, Front Cell Infect Microbiol, 7, 181, 10.3389/fcimb.2017.00181 · DOI · Paper page
- Frees, 2004, Clp ATPases are required for stress tolerance, intracellular replication and biofilm formation in Staphylococcus aureus, Mol Microbiol, 54, 1445, 10.1111/j.1365-2958.2004.04368.x · DOI · Paper page
- Karimaei, S., et al., Antibiotic tolerance in biofilm persister cells of Staphylococcus aureus and expression of toxin-antitoxin system genes. 2021. 159: p. 105126. https://doi.org/10.1016/j.micpath.2021.105126 · DOI
- Zhao, N., et al., Molybdopterin biosynthesis pathway contributes to the regulation of SaeRS two-component system by ClpP in Staphylococcus aureus. 2022. 13(1): p. 727–39. https://doi.org/10.1080/21505594.2022.2065961 · DOI
- Mawla, G.D., et al., ClpP1P2 peptidase activity promotes biofilm formation in Pseudomonas aeruginosa. 2021. 115(6): p. 1094–109. https://doi.org/10.1111/mmi.14649 · DOI
- Malishev, R., et al., Inhibition of Staphylococcus aureus biofilm-forming functional amyloid by molecular tweezers. 2021. 28(9): p. 1310–20. e5. https://doi.org/10.1016/j.chembiol.2021.03.013 · DOI
- Bhardwaj S, Roy KK. ClpP peptidase as a plausible target for the discovery of novel antibiotics. 2024. 25(2): p. 108–20. https://doi.org/10.2174/0113894501274958231220053714 · DOI
- Kim, G.-L., L. Akoolo, D. Parker, The ClpXP protease contributes to Staphylococcus aureus pneumonia. 2020. 222(8): p. 1400–4. https://doi.org/10.1093/infdis/jiaa251 · DOI
- Karimaei, S., S.M.K. Aghamir, M.R. Pourmand, Comparative analysis of genes expression involved in type II toxin-antitoxin system in Staphylococcus aureus following persister cell formation. 2024. 51(1): p. 324. https://doi.org/10.1007/s11033-023-09179-6 · DOI
- Malik, I.T., et al., Functional characterisation of ClpP mutations conferring resistance to acyldepsipeptide antibiotics in Firmicutes. 2020. 21(14): p. 1997–2012. https://doi.org/10.1002/cbic.201900787 · DOI
- Yu, H., et al., Synergistic efficacy of high-intensity ultrasound and chlorine dioxide combination for Staphylococcus aureus biofilm control. 2021. 122: p. 107822.https://doi.org/10.1016/j.foodcont.2020.107822 · DOI
- Chen, J., et al., 20S-ginsenoside Rg3 inhibits the biofilm formation and haemolytic activity of Staphylococcus aureus by inhibiting the SaeR/SaeS two-component system. 2022. 71(10): p. 001587. https://doi.org/10.1099/jmm.0.001587 · DOI
- Gao, P., et al., SaeR as a novel target for antivirulence therapy against Staphylococcus aureus. 2023. 12(2): p. 2254415. https://doi.org/10.1080/22221751.2023.2254415 · DOI
- Zheng, X., et al., Antibacterial and anti-biofilm efficacy of chinese dragon’s blood against Staphylococcus aureus isolated from infected wounds. 2021. 12: p. 672943. https://doi.org/10.3389/fmicb.2021.672943 · DOI
- Xiaohua, T., et al., Effect of resveratrol on biofilm formation in Staphylococcus aureus. 2023. 29(14): p. 1950. https://doi.org/10.1016/j.jprot.2021.104357 · DOI
- Matsumoto, M., et al., Interaction between Staphylococcus Agr virulence and neutrophils regulates pathogen expansion in the skin. 2021. 29(6): p. 930–40. e4. https://doi.org/10.1016/j.chom.2021.03.007 · DOI
- Wang, H., et al., The antiviral drug efavirenz reduces biofilm formation and hemolysis by Staphylococcus aureus. 2021. 70(10): p. 001433. https://doi.org/10.1099/jmm.0.001433 · DOI
- Park, I., et al., Antivirulence activities of retinoic acids against Staphylococcus aureus. 2023. 14: p. 1224085. https://doi.org/10.3389/fmicb.2023.1224085 · doi:10.3389/fmicb.2023.1224085
- Luo, Z., et al., The role of male hormones in bacterial infections: enhancing Staphylococcus aureus virulence through testosterone-induced Agr activation. 2024. 206(10): p. 401. https://doi.org/10.1007/s00203-024-04130-0 · DOI
- Ahator, S.D., et al., Comprehensive virulence profiling and evolutionary analysis of specificity determinants in Staphylococcus aureus two-component systems. 2024. 9(4): p. e00130–24. https://doi.org/10.1128/msystems.00130-24 · DOI
- Yang, B., et al., Breaking CHIPS-Mediated immune evasion with tripterin to promote neutrophil chemotaxis against MRSA infection. 2024. 129: p. 111597. https://doi.org/10.1016/j.intimp.2024.111597 · doi:10.1016/j.intimp.2024.111597
- Xiao, Y., et al., Phylogenetic analysis and virulence characteristics of methicillin-resistant Staphylococcus aureus ST764-SCC mec II: an emerging hypervirulent clone ST764-t1084 in China. 2023. 12(1): p. 2165969. https://doi.org/10.1080/22221751.2023.2165969 · DOI
- Na, M., et al., The expression of von Willebrand factor-binding protein determines joint-invading capacity of Staphylococcus aureus, a Core mechanism of septic arthritis. 2020. 11(6): p. 10.1128/mbio. 02472-20. https://doi.org/10.1128/mBio.02472-20 · doi:10.1128/mbio.02472-20
- Zhang, C., et al., Bilobetin attenuates Staphylococcus aureus virulence by targeting Von Willebrand factor-binding protein and staphylocoagulase. 2023. 39(12): p. 358. https://doi.org/10.1007/s11274-023-03812-z · doi:10.1007/s11274-023-03812-z
- Nappi F, Avtaar Singh SS. Host–bacterium interaction mechanisms in Staphylococcus aureus endocarditis: a systematic review. 2023. 24(13): p11068. https://doi.org/10.3390/ijms241311068 · DOI
- Evans, D.C., et al., GFP fusions of Sec-routed extracellular proteins in Staphylococcus aureus reveal surface-associated coagulase in biofilms. 2023. 10(7): p. 145. https://doi.org/10.15698/mic2023.07.800 · DOI
- Shang, Y., et al., Clemastine inhibits the biofilm and hemolytic of Staphylococcus aureus through the GdpP protein. 2022. 10(2): p. e00541–21. https://doi.org/10.1128/spectrum.00541-21 · DOI
- Wittekind, M.A., et al., The novel protein ScrA acts through the SaeRS two-component system to regulate virulence gene expression in Staphylococcus aureus. 2022. 117(5): p. 1196–212. https://doi.org/10.1111/mmi.14901 · DOI · Paper page
- Awan, F., et al., Genetic diversity in Staphylococcus aureus and its relation to biofilm production. 2021: p. 23. https://doi.org/10.5772/intechopen.99967 · DOI
- Butrico CE, Cassat JE. Quorum sensing and toxin production in Staphylococcus aureus osteomyelitis: pathogenesis and paradox. 2020. 12(8): p. 516. https://doi.org/10.3390/toxins12080516 · DOI · Paper page
- Cheng, X., et al., Resistance phenotype and genetic features of a heterogeneous Vancomycin intermediate–resistant Staphylococcus aureus strain from an immunocompromised patient. 2024. 55(1): p. 323–32. https://doi.org/10.1007/s42770-023-01192-y · DOI
- Cheung, G.Y., J.S. Bae, M. Otto, Pathogenicity and virulence of Staphylococcus aureus. 2021. 12(1): p. 547–69. https://doi.org/10.1080/21505594.2021.1878688 · DOI · Paper page
- Loges, L.A., et al., Polyketides from marine-derived Aspergillus welwitschiae inhibit Staphylococcus aureus virulence factors and potentiate vancomycin antibacterial activity in vivo. 2020. 143: p. 104066. https://doi.org/10.1016/j.micpath.2020.104066 · doi:10.1016/j.micpath.2020.104066
- Jacob, B., et al., In vitro additive effects of dalbavancin and rifampicin against biofilm of Staphylococcus aureus. 2021. 11(1): p. 23425. https://doi.org/10.1038/s41598-021-02709-x · DOI
- Yasir, M., D. Dutta, M.D. Willcox, Enhancement of antibiofilm activity of ciprofloxacin against Staphylococcus aureus by administration of antimicrobial peptides. 2021. 10(10): p. 1159. https://doi.org/10.3390/antibiotics10101159 · DOI
- Jasim, N.A., et al., ZnO nanoparticles inhibit growth and biofilm formation of vancomycin-resistant S. aureus (VRSA). 2020. 29: p. 101745. https://doi.org/10.1016/j.bcab.2020.101745 · DOI
- A.Hashimoto, The combination of silver-containing hydroxyapatite coating and vancomycin has a synergistic antibacterial effect on methicillin-resistant, Staphylococcus aureus biofilm formation. 2020. 9(5): p. 211–8. https://doi.org/10.1302/2046-3758.95.BJR-2019-0326.R1 · doi:10.1302/2046-3758.95.bjr-2019-0326.r1
- Zhou, Y., et al., New attempts to inhibit methicillin-resistant Staphylococcus aureus Biofilm? A combination of daptomycin and azithromycin. 2023: p. 7029–40. https://doi.org/10.2147/IDR.S433439 · DOI
- Hou, H., et al., The crafty opponent: the defense systems of Staphylococcus aureus and response measures. 2022. 67(2): p. 233–43. https://doi.org/10.1007/s12223-022-00954-9 · DOI
- Bai, Z., et al., Multifaceted materials for enhanced osteogenesis and antimicrobial properties on bioplastic polyetheretherketone surfaces: a review. 2024. 9(16): p. 17784–807. https://doi.org/10.1021/acsomega.4c00923 · DOI
- Pierezan, 2022, Relevant safety aspects of raw milk for dairy foods processing, 211, 10.1016/bs.afnr.2022.01.001 · DOI
- Marcone, G.L., et al., D-amino acids in foods. 2020. 104: p. 555–74. https://doi.org/10.1007/s00253-019-10264-9 · DOI
- Warraich, A.A., et al., Evaluation of anti-biofilm activity of acidic amino acids and synergy with ciprofloxacin on Staphylococcus aureus biofilms. 2020. 10(1): p. 9021. https://doi.org/10.1038/s41598-020-66082-x · DOI
- Seo, S., et al., Antimicrobial peptides encounter resistance of aureolysin during their action on Staphylococcus aureus biofilm. 2021. 26(2): p. 216–22. https://doi.org/10.1007/s12257-020-0384-z · doi:10.1007/s12257-020-0384-z
- Warsi, O.M., et al., Staphylococcus aureus mutants resistant to the feed-additive monensin show increased virulence and altered purine metabolism. 2024. 15(2): p. e03155–23. https://doi.org/10.1128/mbio.03155-23 · DOI
- Moghadam, M.J., et al., Inhibitory activity of oliveria decumbens essential oil on Staphylococcus aureus biofilm and planktonic cells. 2022. 9(3): p. 109–14. https://doi.org/10.34172/ajcmi.2022.3397 · doi:10.34172/ajcmi.2022.3397
- Monteiro-Neto, V., et al., Cuminaldehyde potentiates the antimicrobial actions of ciprofloxacin against Staphylococcus aureus and Escherichia coli. 2020. 15(5): p. e0232987. https://doi.org/10.1371/journal.pone.0232987 · DOI
- da Silva, R.A., I. Afonina, K.A. Kline, Eradicating biofilm infections: an update on current and prospective approaches. 2021. 63: p. 117–25. https://doi.org/10.1016/j.mib.2021.07.001 · DOI
- Zurawski DV, McLendon MK. Monoclonal antibodies as an antibacterial approach against bacterial pathogens. 2020. 9(4): p. 155. https://doi.org/10.3390/antibiotics9040155 · DOI · Paper page
- Han J, Poma A. Molecular targets for antibody-based anti-biofilm therapy in infective endocarditis. 2022. 14(15): p. 3198. https://doi.org/10.3390/polym14153198 · DOI
- Chung PY. Immunotherapies for the prevention and treatment of Staphylococcus aureus infections: updates and challenges. 2023(81): pftad016. https://doi.org/10.1093/femspd/ftad016 · DOI
- Mayor, A., et al., Therapeutic antibodies for the treatment of respiratory tract infections—current overview and perspectives. 2021. 9(2): p. 151. https://doi.org/10.3390/vaccines9020151 · DOI
- Kharga, K., L. Kumar, S.K.S. Patel, Recent advances in monoclonal antibody-based approaches in the management of bacterial sepsis. 2023. 11(3): p. 765. https://doi.org/10.3390/biomedicines11030765 · DOI · Paper page
200 of 253 shown
Cited by
Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms
Touaitia, R., Mairi, A., Ibrahim, N. A., Basher, N. S., Idres, T., & Touati, A. (2025) · Antibiotics · doi:10.3390/antibiotics14050470 · Cited by 273
Metadata
- Authors
- Wang, D., Wang, L., Liu, Q., & Zhao, Y.
- Venue
- Animals and Zoonoses
- Publisher
- Elsevier BV
- Published
- 2025-06
- Volume
- 1
- Issue
- 2
- Pages
- 188-202
- ISSN
- 2950-2489
- Cited by
- 57
- References
- 3
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Funders
- Science and Technology Department of Tibet Autonomous Region (CGZH2023000195)
- State Key Laboratory for Diagnosis and Treatment of Infectious Diseases (RCGHCRB202405)
- Jilin Scientific and Technological Development Program (20240207010CX)
- National Natural Science Foundation of China (U22A20340)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Virulence factors in biofilm formation and therapeutic strategies for Staphylococcus aureus: A review. https://app.cochat.ai/papers/10.1016/j.azn.2024.11.003
- The paper
- Wang, D., Wang, L., Liu, Q., & Zhao, Y. (2025). Virulence factors in biofilm formation and therapeutic strategies for Staphylococcus aureus: A review. Animals and Zoonoses. https://doi.org/10.1016/j.azn.2024.11.003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.